Zhonghong Medical's revenue reached 23.73 billion yuan in 2025, with a net loss attributable to shareholders of 112 million yuan. The proportion of health protection revenue increased to 87.92%.

In 2025, the company's revenue reached 2.373 billion yuan (-3.40%), with a net loss attributable to shareholders of 112 million yuan (-28.98%). The main business faced pressure primarily due to the cyclical downturn in the protective gloves industry, currency appreciation, and asset impairment. Revenue from health protection and safe infusion accounted for 94.81% of total revenue, while the proportion of overseas sales increased to 80.76%. However, the decline in gross margin resulted in a net profit margin of -4.92%. Operating cash flow plummeted by 97.97%, and R&D personnel growth significantly outpaced investment growth, leading to an expanded non-recurring loss of -177 million yuan.

lanjinger.comApr 27 15:26

Zhonghong Pulin Medical Products: First Quarter Report 2026

SZSIApr 27 00:00 · Announcements

Zhonghong Pulin Medical Products: Annual Report 2025

SZSIApr 27 00:00 · Announcements

Zhonghong Pulin Medical Products: Summary of the Annual Report for 2025

SZSIApr 27 00:00 · Announcements

Zhonghong Medical (300981): Price increase of nitrile gloves expected to drive significant profit growth; Indonesia expansion project supports future development.

Event: Since early March, the rise in crude oil prices has driven up the prices of basic chemical raw materials such as 'butadiene,' which has led to an increase in intermediate materials like 'nitrile latex' required for glove production. This ultimately resulted in higher production costs for nitrile gloves, reflected in the price of nitrile gloves.

Cinda SecuritiesApr 7 18:21

Express News | The concept of medical consumables surged amid market volatility, with Yingke Medical rising over 10%, hitting a more than four-year high.

BreakingsApr 7 10:16